Jadvar, H., Colletti, P. M., Delgado-Bolton, R., Esposito, G., Krause, B. J., Iagaru, A. H., … Griffeth, L. (2017). Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease. J Nucl Med, 58(12), 2026–2037. https://doi.org/10.2967/jnumed.117.197988

Jadvar, Hossein, Patrick M. Colletti, Roberto Delgado-Bolton, Giuseppe Esposito, Bernd J. Krause, Andrei H. Iagaru, Helen Nadel, et al. “Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease.” J Nucl Med 58, no. 12 (December 2017): 2026–37. https://doi.org/10.2967/jnumed.117.197988.

Jadvar H, Colletti PM, Delgado-Bolton R, Esposito G, Krause BJ, Iagaru AH, et al. Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease. J Nucl Med. 2017 Dec;58(12):2026–37.

Jadvar, Hossein, et al. “Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease.” J Nucl Med, vol. 58, no. 12, Dec. 2017, pp. 2026–37. Pubmed, doi:10.2967/jnumed.117.197988.

Jadvar H, Colletti PM, Delgado-Bolton R, Esposito G, Krause BJ, Iagaru AH, Nadel H, Quinn DI, Rohren E, Subramaniam RM, Zukotynski K, Kauffman J, Ahuja S, Griffeth L. Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease. J Nucl Med. 2017 Dec;58(12):2026–2037.